plko 1 control shrna vector targeting gfp (Addgene inc)
95
Structured Review
Addgene inc
plko 1 control shrna vector targeting gfp
Plko 1 Control Shrna Vector Targeting Gfp, supplied by Addgene inc, used in various techniques. Bioz Stars score: 95/100, based on 173 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/plko+1+control+shrna+vector+targeting+gfp/pLKO%2E1+GFP+shRNA+(Plasmid+%2330323)/pmc12482338__10020_2025_1353_MOESM4_ESM-35-22-34
Average 95 stars, based on 173 article reviews
Plko 1 Control Shrna Vector Targeting Gfp, supplied by Addgene inc, used in various techniques. Bioz Stars score: 95/100, based on 173 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/plko+1+control+shrna+vector+targeting+gfp/pLKO%2E1+GFP+shRNA+(Plasmid+%2330323)/pmc12482338__10020_2025_1353_MOESM4_ESM-35-22-34
Average 95 stars, based on 173 article reviews
plko 1 control shrna vector targeting gfp - by Bioz Stars,
2026-09
95/100 stars
Images
Related Articles
shRNA:Article Title: Selective inhibition of BRAF and CRAF sensitizes NF1-deficient malignant peripheral nerve sheath tumors to MEK inhibitors Article Snippet: .. Lentivirus-based shRNA/ sgRNA-mediated knockdown cells pLKO.1 lentiviral shRNA vectors targeting ARAF, BRAF and CRAF were obtained from Dr. Deborah Morrison, NCI (6). Knockdown:Article Title: Selective inhibition of BRAF and CRAF sensitizes NF1-deficient malignant peripheral nerve sheath tumors to MEK inhibitors Article Snippet: .. Lentivirus-based shRNA/ sgRNA-mediated knockdown cells pLKO.1 lentiviral shRNA vectors targeting ARAF, BRAF and CRAF were obtained from Dr. Deborah Morrison, NCI (6). Control:Article Title: Selective inhibition of BRAF and CRAF sensitizes NF1-deficient malignant peripheral nerve sheath tumors to MEK inhibitors Article Snippet: .. Lentivirus-based shRNA/ sgRNA-mediated knockdown cells pLKO.1 lentiviral shRNA vectors targeting ARAF, BRAF and CRAF were obtained from Dr. Deborah Morrison, NCI (6). |